News archive for Neuro-SysMed
The results of a new clinical trial, published in the peer-reviewed journal Cell Metabolism, show that oral intake of nicotinamide riboside (NR) enhances NAD-metabolism in the brain of individuals with Parkinson鈥檚 disease, and shows promise as a potential therapy.
- December 2024 (2)
- October 2024 (1)
- June 2024 (3)
- May 2024 (3)
- October 2023 (1)
- September 2023 (1)
- May 2023 (2)
- December 2022 (1)
- November 2022 (2)
- March 2022 (1)